Alaunos Therapeutics TCRT
NASDAQ TCRT
$1.71 +0.04 (+2.40%)
At close: Nov 10, 2026 · 4:00 PM EST

Alaunos Therapeutics (TCRT) Operating Leases (2020 - 2021)

Updated

Alaunos Therapeutics (TCRT) reported Operating Leases of $4.71 million for Q3 2021, down 3.7% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Operating Leases (2020 - 2021) Analysis & Trends

At the end of FY2020, Alaunos Therapeutics posted Operating Leases of $4 million.

  • Five-year quarterly Operating Leases spans a low of $3.87 million in Q1 2021 and a high of $4.89 million in Q2 2021.
  • Per Business Quant data, the three quarters before Q3 2021 came in at $4.89 million (Q2 2021), $3.87 million (Q1 2021) and $4 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Alaunos Therapeutics 4.38 Mn 576,050.88 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 4.71 Mn
Jun 30, 2021 4.89 Mn
Mar 31, 2021 3.87 Mn
Dec 31, 2020 4.00 Mn
API Access

Alaunos Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=TCRT&period=max&api_key=YOUR_API_KEY